Immunogenicity and safety study of Indirab: A Vero cell based chromatographically purified human rabies vaccine

Vaccine

Volumn 28, Issue 24, 2010, Pages 4086-4090

  Sampath, Gadey ^a   Madhusudana, Shampur Narayan ^b   Sudarshan, Mysore Kalappa ^c   Ashwathnarayana, Doddabele Hanumanthaiah ^c   Mahendra, Bangalore Jayakrishna ^d   Ullas, Thankappan P ^b   Mohan, Krishna ^e   Madhusudhan, Santhosh Kumar ^e   Ravish, Haradanahalli Shankariah ^c  

^a Institute of Preventive Medicine   (India)

^b NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^c KEMPEGOWDA INSTITUTE OF MEDICAL SCIENCES   (India)

^d Mandya Institute of Medical Sciences ^*  (India)

^e Bharat Biotech International Limited   (India)

Author keywords

Chromatographically purified Vero cell rabies vaccine; Purified Vero cell rabies vaccine; Rabies; Rabies vaccines

Indexed keywords

EQUIRAB; INDIRAB; NEUTRALIZING ANTIBODY; RABIES IMMUNOGLOBULIN; RABIES VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CHROMATOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG FEVER; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; MALE; MULTICENTER STUDY; NORMAL HUMAN; PAIN; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SWELLING; VACCINE PRODUCTION; VERO CELL;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CERCOPITHECUS AETHIOPS; CHILD; CHROMATOGRAPHY; FEMALE; HUMANS; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; RABIES; RABIES VACCINES; VERO CELLS; YOUNG ADULT;

EID: 77952583478     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.03.064     Document Type: Article

References (14)

1. World Health Organization. World survey of rabies No 35 for the year 1999 (2002), WHO/CDS/CSR/EPH/2002.10, Geneva
2. Sudarshan M.K., Madhusudana S.N., Mahendra B.J., Rao N.S., Ashwathnarayana D.H., Abdul Rahman S., et al. Assessing burden of human rabies in India: results of a national multi-center epidemiological survey. Int J Infect Dis 11 1 (2007) 29-35
3. Lang J., Cetre J.C., Picot N., Lanta M., Briantais P., Vital S., et al. Immunogenicity and safety in adults of a new chromatographically purified vero-cell rabies vaccine (CPRV): a randomized double blind trial with purified vero cell rabies vaccine (PVRV). Biologicals 26 (1998) 295-308
4. Quiambao B.P., Lang J., Vital S., Montalban C.G., Le Mener V., Wood S.C., et al. Immunogenicity and effectiveness of post-exposure rabies prophylaxis with a new chromatographically purified vero-cell rabies vaccine (CPRV): a two stage randomized clinical trial in the Philippines. Acta Trop 75 (2000) 39-52
5. Smith J.S., Yager P.A., and Baer G.M. A rapid fluorescent focus inhibition test (RFFIT) for determining rabies-neutralizing antibody. In: Meslin F.X., Koprowsky H., and Kaplan M.M. (Eds). Laboratory techniques in rabies. 4th ed. (1996), WHO, Geneva 181-192
6. World Health Organization. WHO expert committee on biological standardization 37th report. WHO Tech Rep Ser 760 (1987), WHO, Geneva
7. Montagnon B.J. Polio and rabies vaccines produced in continuous cell lines. A reality for vero cell line. Dev Biol Stand 70 (1989) 27-47
8. World Health Organization. WHO expert committee on rabies: 8th report. WHO Tech Rep Ser 824 (1992), WHO, Geneva
9. Chutivongse S., Supich C., and Wilde H. Acceptability and efficacy of purified vero-cell rabies vaccine in Thai children. Asia Pac J Public Health 2 (1988) 179-185
10. Sudarshan M.K., Madhusudana S.N., and Mahendra B.J. Post-exposure prophylaxis of purified vero cell rabies vaccine (PVRV) during pregnancy: safety and immunogenicity study. J Commun Dis 31 4 (1999) 229-236
11. Sampath G., Reddy S.V., Prasada Rao M.L., Rao Y.U., and Palaniappan C. An immunogenicity study of a newly introduced vero cell rabies vaccine (Abhayrab) manufactured in India. Vaccine 23 (2000) 897-900
12. Briggs D.J., Banzhoff A., Nicolay U., Sirikwin S., Dumavibhat B., Tongswas S., et al. Antibody response in patients after post-exposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified vero-cell rabies vaccine. Bull World Health Org 78 (2000) 683-687
13. World Health Organization. Requirements for rabies vaccines for human use produced in continuous cell lines (amendment 1992) WHO expert committee on biological Standardization. 43rd report WHO Tech rep Ser 840 (1992), WHO, Geneva
14. World Health Organization. Expert consultation on rabies 2004. WHO Tech Rep Ser, 931 (2005), WHO, Geneva